Abstract:Background: Sophora flavescens aiton (SFA) and its main bioactive metabolite matrine are widely used in traditional Chinese medicine (TCM) preparations and have achieved good curative effects for the treatment of various tumors. However, the mechanisms underlying SFA and matrine individually and in combination with chemotherapeutic drugs for treatment of gastric cancer (GC) remain unclear. Aim of the study: To elucidate the mechanisms underlying the ability of SFA and matrine individually and in combination with chemotherapeutic drugs to inhibit proliferation and promote apoptosis of human GC cells. Materials and methods: Forty-eight nude mice were randomly divided into six groups that were treated with normal saline (model group), 5-fluorouracil (5-FU), SFA decoction (SFAD), matrine, SFAD+5-FU, or matrine+5-FU. A subcutaneous heterotopic tumor model was established in nude mice by implantation of human GC BGC-823 cells. All mice were treated for 28 days. Bioactive metabolites in SFA were determined by HPLC-MS/MS. The tumor volume, tumor weight, and tumor inhibition rate of mice were documented. Histopathology and ultramicroscopic pathology of tumor tissues were observed. The tumor cell cycle and apoptosis in vivo were detected. Serum levels of PCNA, BAX, Bcl-2, Caspase-9, Caspase-3 and cleaved Caspase-3 were measured. Protein levels of MS4A10, MS4A8, MS4A7, PCNA, BAX, Bcl-2, Caspase-3, and cleaved Caspase-3 were measured in tumor tissues. Results: Both SFAD and matrine inhibited the growth of transplanted GC cells, which was more effective when combined with 5-FU. The tumor inhibition rates of the 5-FU, SFAD, matrine, SFAD+5-FU, and matrine+5-FU groups were 53.85%, 33.96%, 30.44%, 59.74%, and 56.55%, respectively. The body weight of tumor-bearing nude mice was greater in the SFAD group than the normal saline and matrine groups. SFAD+5-FU and matrine+5-FU blocked BGC-823 cells in the G 0 -G 1 /S transition, promoted apoptosis, and significantly decreased the content of serum apoptosis-inhibitory proteins (PCNA and Bcl-2) as well as protein expression of MS4A8, MS4A10, Bcl-2, and PCNA in tumor tissues, while increasing serum levels of pro-apoptotic proteins (Caspase-9, Caspase-3 and cleaved-Caspase-3) and protein expression of BAX and cleaved-Caspase-3 in tumor tissues. Conclusion: SFAD and matrine both individually and in combination with 5-FU ameliorated malignancy of transplanted tumors by reducing proliferation and promoting apoptosis of BGC-823 cells. These findings confirm the anti-tumor synergistic effect of TCM and chemotherapeutic drugs.

Molecular and cellular effects of nutrients : global perspectives and modern aspects Paeoniflorin suppress NFk B activation through modulation of I k B a and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells

Paeoniflorin suppress NF-κB activation through modulation of IκBα and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells

Polyunsaturated Fatty Acids Augment Tumoricidal Action Of 5-Fluorouracil On Gastric Cancer Cells By Their Action On Vascular Endothelial Growth Factor, Tumor Necrosis Factor-Alpha And Lipid Metabolism Related Factors

Effect of paeoniflorin on apoptosis of human gastric cancer SGC7901 /VCR cells and its mechanism

Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.

Parthenolide Augments the Anticancer Effects of 5-Fluorouracil on Cell Apoptosis and Decreased Nf-Kappa B Activity in A Gastric Cancer Cell Line

Paeoniflorin Modulates Multidrug Resistance of a Human Gastric Cancer Cell Line Via the Inhibition of NF-κB Activation.

Paeoniflorin Inhibits IL-1β-induced Chondrocyte Apoptosis by Regulating the Bax/Bcl-2/caspase-3 Signaling Pathway

The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art

Digitoflavone Inhibits IκBα Kinase and Enhances Apoptosis Induced by TNFα Through Downregulation of Expression of Nuclear Factor Κb-Regulated Gene Products in Human Pancreatic Cancer Cells

Paeonol‑mediated Apoptosis of Hepatocellular Carcinoma Cells by NF‑κB Pathway

Deciphering the action mechanism of paeoniflorin in suppressing pancreatic cancer: A network pharmacology study and experimental validation

Effect of NF-κB Constitutive Activation on Proliferation and Apoptosis of Gastric Cancer Cell Lines

Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma

Paeoniflorin inhibits hepatocellular carcinoma growth by reducing PD-L1 expression

Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathway.

Effects of Sophora flavescens aiton and the absorbed bioactive metabolite matrine individually and in combination with 5-fluorouracil on proliferation and apoptosis of gastric cancer cells in nude mice

Involvement of the Prostaglandin E Receptor EP2 in Paeoniflorin-Induced Human Hepatoma Cell Apoptosis

Therapeutic effects of paeonol on non‐small cell lung cancer cells via regulation of the MAPK pathway

Molecular Mechanism of Paeoniflorin Regulating Transforming Growth Factor-Β in Inhibiting the Epithelial-Mesenchymal Transition of Glioma U87 Cells

Paeoniflorin Inhibits Glioblastoma Growth in Vivo and in Vitro: a Role for the Triad3A-dependent Ubiquitin Proteasome Pathway in TLR4 Degradation